A 35-year-old man with generalized weakness, ptosis, and difficulty swallowing.
A 35-year-old man without previous history of systemic illness presents to our clinic with generalized weakness, more prominent on the right side, ptosis, and difficulty swallowing for six months.
Figure 1: Axial CT image and 3D CT reconstruction show a lytic lesion at the right mandibular angle (yellow arrows).
Figure 2: Axial CT images show multiple lytic lesions at the right iliac bone (yellow arrows). 3D CT reconstruction shows a large lytic lesion at the right iliac crest (red arrow).
Figure 3: DSA shows a highly vascularized lesion at C1 vertebra.
Figure 4: Sagittal CT image and 3D reconstruction shows lytic lesions at the right mandibular angle, odontoid process, and C4 vertebra (yellow and black arrows).
Figure 5: Axial CT image shows destruction of the C1 arch (yellow arrow).
Figure 6: Coronal and sagittal CT images show an aggressive, necrotic, and vascularized lesion occupying the right hepatic lobe and hepatorenal fossa.
Figure 7: Histological tissue section shows positive staining for chromogranin.
Figure 8: Histological tissue section shows positive staining for neuro-specific enolase (NSE).
Imaging studies disclosed multiple skeletal lytic lesions, a large hepatic lesion, and a highly vascularized cervical vertebral mass (Figures 1-6). Histological immunostaining for chromogranin and neurospecific enolase (NSE) was performed and were positive, thus confirming the diagnosis of metastatic pheochromocytoma (Figures 7 and 8).
Diagnosis: Pheochromocytoma with hepatic, mandibular, and vertebral metastasis
Diagnosis was also confirmed clinically with increased catecholamine levels as follows: urine total metanephrine (2,680 mcg/g creat; normal 94-445), urine normetanephrine (2,583 mcg/g creat; normal 67-390); plasma total metanephrine (1,559 pg/ml; normal < 205) and plasma normetanephrine (1,502 pg/ml; normal < 148).
Guido Santacana-Laffitte, MD, and Jomarie Cortés, MD, Department of Diagnostic Radiology, University of Puerto Rico School of Medicine
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.